Engineers Gate Manager’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
DM
SCM
HA
FBIL
Engineers Gate Manager's LEGN Position: Q1 2026 in Review
Engineers Gate Manager reduced its Legend Biotech (LEGN) stake by 82% in Q1 2026, selling an estimated $1.67M and leaving 18,715 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #1645.
Engineers Gate Manager first reported a position in LEGN in Q2 2023 and has held it in 12 quarters since. The position peaked at $2.31M in Q4 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.
- Engineers Gate Manager held 18,715 shares of Legend Biotech worth $339K as of Q1 2026.
- Engineers Gate Manager sold 87,425 Legend Biotech shares in Q1 2026, an estimated $1.67M.
- Legend Biotech made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1645 holding.
- Engineers Gate Manager first reported a position in Legend Biotech in Q2 2023 and has held it in 12 quarters since.
- Engineers Gate Manager's Legend Biotech position peaked at $2.31M in Q4 2025.
- 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.
Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.